Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)
Clinical trial NCT04223778 · COMPLETED
Trial details
- NCT number
- NCT04223778
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2021-09-08
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.